Applied Intuition vs Vannevar Labs: employee equity compared
Secondary market prices, valuation trajectory, equity structure, and liquidity outlook for employees choosing between Applied Intuition and Vannevar Labs.
Applied Intuition
Autonomous vehicle and ADAS software platform; tools for simulation, data management, and validation used by 19 of the 25 largest global automakers.
IPO plausible 2027–2029 if growth trajectory holds. Secondary indication near primary round valuation. Liquidity may come via tender offer or strategic acquisition before listing.
Government-contract stability; ISO/NSO options; longer liquidity timeline vs consumer tech
Vannevar Labs
AI-native defence intelligence platform processing open-source, commercial, and classified data for the DoD and IC.
Early-stage — IPO 4–6+ years away. High-risk, high-upside equity. Liquidity most likely via acquisition or late-stage tender.
Government-contract stability; ISO/NSO options; longer liquidity timeline vs consumer tech
Key differences for employees
Equity structure
Applied Intuition grants ISO/NSO with strike prices ranging from $60–$100 depending on your grant year. Vannevar Labs grants ISO/NSO with strike prices from $7–$14.
Secondary market premium
The secondary market is pricing Applied Intuition at a +11% premium over its last primary round ($15B → $16.6B). Vannevar Labs trades at +0% over its last round ($1.2B → $1.2B). A higher secondary premium signals stronger investor demand and potentially better near-term liquidity for employees looking to sell.
Revenue and growth
Applied Intuition runs at $0.3B ARR, growing +200% YoY (very fast). Vannevar Labs runs at $0.1B ARR, growing +80% YoY (fast). Revenue growth rate matters for equity because it drives the peer-multiple valuation — the method most correlated with exit multiples.
Liquidity timeline
Applied Intuition: IPO plausible 2027–2029 if growth trajectory holds. Secondary indication near primary round valuation. Liquidity may come via tender offer or strategic acquisition before listing.
Vannevar Labs: Early-stage — IPO 4–6+ years away. High-risk, high-upside equity. Liquidity most likely via acquisition or late-stage tender.
Calculate your specific grant
Enter your actual shares, equity type, and strike price. PrivatePulse calculates your personal equity value at both companies using 4 independent methods.